Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · IEX Real-Time Price · USD
0.179
0.00 (-0.06%)
Jul 19, 2024, 4:00 PM EDT - Market closed

MTNB Statistics

Total Valuation

MTNB has a market cap or net worth of $44.97 million. The enterprise value is $40.21 million.

Market Cap 44.97M
Enterprise Value 40.21M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date Aug 7, 2024
Ex-Dividend Date n/a

Share Statistics

MTNB has 250.82 million shares outstanding. The number of shares has increased by 0.04% in one year.

Shares Outstanding 250.82M
Shares Change (YoY) +0.04%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 2.53%
Owned by Institutions (%) 11.19%
Float 244.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.09
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.15, with a Debt / Equity ratio of 0.23.

Current Ratio 5.15
Quick Ratio n/a
Debt / Equity 0.23
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -109.70% and return on invested capital (ROIC) is -134.11%.

Return on Equity (ROE) -109.70%
Return on Assets (ROA) -85.70%
Return on Capital (ROIC) -134.11%
Revenue Per Employee n/a
Profits Per Employee -$726,656
Employee Count 32
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -48.82% in the last 52 weeks. The beta is 1.70, so MTNB's price volatility has been higher than the market average.

Beta (5Y) 1.70
52-Week Price Change -48.82%
50-Day Moving Average 0.17
200-Day Moving Average 0.21
Relative Strength Index (RSI) 59.85
Average Volume (20 Days) 887,688

Short Selling Information

The latest short interest is 2.24 million, so 0.89% of the outstanding shares have been sold short.

Short Interest 2.24M
Short Previous Month 2.36M
Short % of Shares Out 0.89%
Short % of Float 0.92%
Short Ratio (days to cover) 2.99

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -24.08M
Pretax Income -23.25M
Net Income -23.25M
EBITDA -22.30M
EBIT -23.25M
Earnings Per Share (EPS) -$0.12
Full Income Statement

Balance Sheet

The company has $8.16 million in cash and $3.40 million in debt, giving a net cash position of $4.76 million or $0.02 per share.

Cash & Cash Equivalents 8.16M
Total Debt 3.40M
Net Cash 4.76M
Net Cash Per Share $0.02
Equity (Book Value) 14.56M
Book Value Per Share 0.06
Working Capital 8.29M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.96 million and capital expenditures -$218,000, giving a free cash flow of -$17.18 million.

Operating Cash Flow -16.96M
Capital Expenditures -218,000
Free Cash Flow -17.18M
FCF Per Share -$0.08
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MTNB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.04%
Shareholder Yield -0.04%
Earnings Yield -51.71%
FCF Yield -38.20%

Analyst Forecast

The average price target for MTNB is $3.00, which is 1,573.17% higher than the current price. The consensus rating is "Strong Buy".

Price Target $3.00
Price Target Difference 1,573.17%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 156.84%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2